RankingsPricing
  1. JP-listed companies
  2. BrightPath Biotherapeutics Co., Ltd.
  3. Financials
  4. Retained earnings

BrightPath Biotherapeutics Co., Ltd.JP:4594

Market cap
¥4.5B
P/E ratio
-3.7x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndRetained earnings (Million JPY)YoY (%)
Mar 31, 2025-3,805+43.38%
Mar 31, 2024-2,654+78.63%
Mar 31, 2023-1,486-86.34%
Mar 31, 2022-10,876+15.80%
Mar 31, 2021-9,392+22.41%
Mar 31, 2020-7,672+31.95%
Mar 31, 2019-5,814+47.95%
Mar 31, 2018-3,930+67.03%
Mar 31, 2017-2,353+89.88%
Mar 31, 2016-1,239+406.52%
Mar 31, 2015-245

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)